Abstract
Increases in cyclic adenosine monophosphate and cyclic guanosine monophosphate content accompany relaxation of isolated strips of opossum and canine lower oesophageal sphincter muscle. The aim ofthis investigation was to characterise these responses in isolated muscle from the human lower oesophageal sphincter. Electrical stimulation of enteric neurons produced a frequency dependent relaxation of the human lower oesophageal sphincter that was sensitive to tetrodotoxin. Furthermore, as previously shown in the opossum and canine lower oesophageal sphincter, cyclic guanosine monophosphate content was significantly raised in muscle strips frozen during maximum electrical field stimulation whereas cyclic adenosine monophosphate content was unchanged. In addition, sodium nitroprusside (EC50=0.1 tM) produced a concentration dependent relaxation of human lower oesophageal sphincter, significantly increased cyclic guanosine monophosphate content, but did not alter cyclic adenosine monophosphate content. Zaprinast (M&B 22948) and SK&F 94120, selective inhibitors of cyclic guanosine monophosphate and cyclic adenosine monophosphate phosphodiesterases, respectively, both relaxed human lower oesophageal sphincter with a potency similar to that seen in the dog or opossum lower oesophageal sphincter. Finally, the 8-bromo analogues of both cyclic adenosine monophosphate (EC50=420 FtM) and cyclic guanosine monophosphate (EC50=100 FM) relaxed the human lower oesophageal sphincter. These studies suggest that in the human, as well as the canine and opossum lower oesophageal sphincter, increases in cyclic nucleotide content are associated with relaxation and increases in cyclic guanosine monophosphate are associated with the relaxation induced by stimulation of enteric neurons.
The lower oesophageal sphincter provides a physiological barrier that prevents reflux of gastric contents into the oesophagus.' Indeed, reflux occurs only during transient or prolonged abolition of this high pressure zone. 23 In man, unlike certain animals, regulation of sphincter tone is, to a large extent, neurogenic, through both excitatory and inhibitory inputs from the vagus nerve. 4 The final common pathway for these inputs is the enteric nervous system. Electrical stimulation of enteric neurons produces a relaxation of the lower oesophageal sphincter in both man and animals. [5] [6] [7] Although the inhibitory neurotransmitters released by this stimulation have not been fully characterised, there is evidence that vasoactive intestinal polypeptide may be one of the substances released by activation of these inhibitory neurons.8 More recently, the relaxant response and change in cyclic nucleotides of isolated lower oesophageal sphincter smooth muscle to neuronal stimulation has been characterised. In both the opossum9 and canine'0 lower oesophageal sphincter, activation of the enteric nervous system by electrical stimulation produces a relaxation that is accompanied by a significant increase in cyclic guanosine monophosphate content but not cyclic adenosine monophosphate, whereas, at least in the opossum lower oesophageal sphincter, addition of vasoactive intestinal polypeptide produces a relaxation that is associated with an increase in cyclic adenosine monophosphate.9 These findings suggest that in two animal species both cyclic adenosine monophosphate and cyclic guanosine monophosphate may be important intracellular mediators of relaxation in this smooth muscle.
Since most ofour current understanding ofthe biochemistry, physiology, and pharmacology of this smooth muscle comes from animal studies, it must be determined if these animal models mimic the human situation. This is especially important in the development of new treatments for gastrointestinal disease. Therefore, the present study was designed to examine the relaxation response of isolated human lower oesophageal sphincter to electrical field stimulation and to a number of pharmacological agents that change cyclic nucleotide content.
Methods

TISSUE STUDIES
Tissue specimens of human gastroesophageal junction were obtained from organ donors through the National Disease Research Interchange (NDRI), Philadelphia, PA. Only samples that arrived less than 14 hours after the aorta had been clamped were used in these experiments as those that took longer to arrive were not viable for study. Upon arrival, these iced samples were placed in an oxygenated Krebs bicarbonate buffer (NaCl, 117-7 mM; KCl, 4-7 mM; CaCl2, 2 5 mM; K2PO4, 1-18mM; MgSO4, 1 18mM; NaCO3, 25 0 mM; glucose, lI1 mM). The junction was cut open and the demarcation between gastric and oesophageal mucosa was marked. The mucosa was then removed by sharp dissection and strips of circular smooth muscle (1 0-15 cm by 0 2 cm) were cut from the gastroesophageal junction.
The tissues were placed in quick release 10 ml organ baths containing oxygenated Krebs buffer at 37°C. In a preliminary experiment, a tension of 1-5 gm provided the largest tissue response to 10 FM acetylcholine -that is, it was the optimum initial tension. Therefore, an initial tension of I and stored at -70°C for subsequent determination of cyclic nucleotide content.
MEASUREMENT OF CYCLIC NUCLEOTIDE CONTENT
Cyclic nucleotide content was measured by radioimmunoassay." Individual frozen tissues (10-15 mg) were homogenised in 1 5 ml of ice cold 10% trichloroacetic acid containing approximately 4000-5000 cpm of 3H-cyclic adenosine monophosphate as a marker of recovery for both cyclic adenosine monophosphate and cyclic guanosine monophosphate. Precipitated protein was removed by centrifugation at 3000 g for [10] [11] [12] [13] [14] [15] minutes. The trichloroacetic acid was removed by four extractions with water saturated ether (4 5 ml). The amount of cyclic adenosine monophosphate or cyclic guanosine monophosphate was determined after acetylation using commercially available kits (New England Nuclear, Boston, MA) and expressed as pmol/mg protein (cyclic adenosine monophosphate) or fmol/mg protein (cyclic guanosine monophosphate).
Protein concentrations were determined by the method of Lowry,') using bovine serum albumin as a standard.
STATISTICAL ANALYSES
All data are expressed as mean (SEM). Differences between two means were determined by Student's t tests with p<0 05 considered significant.
MATERIALS
Cyclic nucleotide radioimmunoassay kits and 3H-cyclic adenosine monophosphate were obtained from New England Nuclear. Zaprinast was generously provided by May and Baker Ltd. SK&F 94120 was provided by Smith Kline and French Laboratories, Welwyn Garden City, UK. Phentolamine was obtained from CibaGeigy and meclofenamic acid from WarnerLambert. All other chemicals were purchased from Sigma Chemical Co.
Results
Since the lower oesophageal sphincter is not an anatomical sphincter but is defined functionally, the response of human smooth muscle from various levels of the gastroesophageal junction to electrical field stimulation was characterised. Typical responses are shown in Figure 1 . Muscle strips obtained from the oesophageal body exhibited a characteristic contraction, produced after the stimulation was terminated, whereas electrical stimulation of the lower oesophageal sphincter region produced a concomitant relaxation. Tissues obtained from the fundic region contracted during maximum electrical field stimulation.
To determine if the relaxation elicited by electrical field stimulation of the human lower oesophageal sphincter was neuronally mediated, the ability of tetrodotoxin to inhibit stimulation induced relaxation was examined. An initial response to a maximal electrical field stimula- 2) . These findings showed that the relaxation produced by electrical stimulation of isolated strips of human lower oesophageal sphincter is neuronally mediated and indicate that the human lower oesophageal sphincter exhibits a tetrodotoxin sensitivity similar to that observed for isolated strips of opossum and canine lower oesophageal sphincter.9 13 In isolated strips of both opossum and canine lower oesophageal sphincter, electrical stimulation produced a frequency dependent relaxation that was accompanied by an increase in cyclic guanosine monophosphate but not cyclic adenosine monophosphate. As shown in Figure  3 , electrical stimulation relaxed isolated human lower oesophageal sphincter in a frequency dependent manner. Furthermore, in tissues frozen during maximum stimulation -that is 8 Hz -cyclic guanosine monophosphate content was significantly increased whereas cyclic adenosine monophosphate content was unchanged (Table I) .
For comparison with our previous studies in other species, the ability of several drugs that have been reported to alter cyclic nucleotide content in other tissues were examined in the isolated human lower oesophageal sphincter. Cumulative addition of sodium nitroprusside, a nitrovasodilator and an activator of the soluble form of guanylate cyclase,'4 to muscle strips of human lower oesophageal sphincter produced a concentration dependent relaxation of this tissue (Fig 4) (Table I) .
To further characterise the human lower oesophageal sphincter, the ability of two isozyme selective inhibitors of cyclic nucleotide phosphodiesterase to relax the sphincter was examined. Zaprinast, an inhibitor of cyclic guanosine monophosphate selective isozyme produced a concentration dependent relaxation of human tissue (Fig 5) . Although cyclic guanosine monophosphate content was increased in all tissues treated with 300 ,uM zaprinast, this increase was not statistically significant, probably because of the small sample size and the variation among the samples (Table II) . In contrast to zaprinast, SK&F 94120, an inhibitor of the phosphodiesterase III isozyme that is a cyclic adenosine monophosphate selective phosphodiesterase,'5 produced a concentration dependent relaxation (Fig 5) that was accompanied by a significant increase in cyclic adenosine monophosphate content without a change in cyclic guanosine monophosphate (Table II) .
Finally, the ability of the membrane permeable analogues of cyclic nucleotides to elicit relaxation was determined. As shown previously in the opossum lower oesophageal sphincter, 8-Br-cyclic adenosine monophosphate produced a concentration dependent relaxation of the human sphincter (Fig 6) . Furthermore, although less potent than 8-Br-cyclic guanosine monophosphate, 8-Br-cyclic adenosine monophosphate also produced a concentration dependent relaxation of this tissue (Fig 6) the human gastroesophageal junction In these experiments, electrical field st produced a contraction that occurr4 cessation of the stimulus in muscle sti 1-2 cm above the demarcation of ti mucosa. This response is characteristic from the oesophageal body. 16 In electrical stimulation produced a rela muscle strips taken from the oe mucosal junction extending toward t area for about 2 In addition, the present study also showed that cumulative addition of SK&F 94120, a selective inhibitor of the type III (high affinity for cyclic adenosine monophosphate) phosphodiesterase isozyme,"' produced a significant relaxation of the human sphincter and a significant increase in cyclic adenosine monophosphate content. In a similar fashion to the opossum9 and canine lower oesophageal sphincter,'" addition of a drug that increases cyclic adenosine monophosphate con-tent also relaxes isolated strips of the human sphincter. Our findings suggest that compounds that increase cyclic adenosine or guanosine monophosphate content will relax the human lower oesophageal sphincter and may provide therapeutic benefit in the treatment of achalasia.
In conclusion, the present study shows that the isolated human lower oesophageal sphincter responds in a manner similar to that of the opossum and dog. These findings validate the use of these species as models for the human. Of special interest was the finding that electrical field stimulation induced relaxation in human lower oesophageal sphincter smooth muscle strips is also associated with an increase in cyclic guanosine monophosphate, but not cyclic adenosine monophosphate. This result is in agreement with our previous observations in both the opossum and canine lower oesophageal sphincter and supports the hypothesis that cyclic guanosine monophosphate is an intracellular mediator of neuronally induced relaxation.
